摘要
目的制备三七总皂苷壳聚糖缓释微球,并对其体外释药特性进行研究。方法采用乳化交联法制备三七总皂苷壳聚糖微球,以粒径分布、包封率、载药量及体外释药速度为评价指标,考察处方因素对壳聚糖微球的影响。并采用正交设计L9(34)对处方进行优化。结果微球的平均粒径为(4.2±0.3)μm,包封率为(28.58±2.76)%(n=3),载药量为(17.15±1.65)%(n=3)。结论通过优化处方和制备工艺,采用乳化交联法制备的三七总皂苷壳聚糖缓释微球,其体外释药具有明显的缓释作用且制备工艺简单。
Objective To prepare and evaluate saponins of Panax notoginseng-chitosan microspheres with sustained-release property. Methods The microspheres were prepared by water/oil emulsion polymerization and by cross-linking with glutaraldehyde. The effects of preparation compositions on particle size, particle morphology, encapsulation efficacy and drug release rate in vitro were investigated by orthogonal design L9 ( 34 ). Results Mean particle size was (4.2 ± 0.3 )μm, encapsulation efficacy was ( 28.58 ± 2.76) % ( n = 3 ), loading efficiency was ( 17.15 ± 1.65 ) % ( n = 3 ). Conclusion Saponins-chitosan microspheres with sustained -release property could be prepared effectively.
出处
《广东药学院学报》
CAS
2006年第5期479-482,共4页
Academic Journal of Guangdong College of Pharmacy
关键词
三七总皂苷
壳聚糖微球
乳化交联法
体外释药
Panax notoginseng
chitosan microspheres
emulsion-chemical cross-link
drug release